{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T09:03:29Z","timestamp":1785315809953,"version":"3.55.0"},"reference-count":65,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Methylglyoxal (MGO), a highly reactive 1,2-dicarbonyl, is generated by all three principal pathways of advanced glycation end product (AGE) synthesis in type 2 diabetes mellitus (T2DM)\u2014the Hodge, Namiki, and Wolff pathways\u2014and by the non-enzymatic degradation of glycolytic triose phosphates. It is the principal substrate of the glutathione-dependent GLO1\/GLO2 glyoxalase system and the main source of the hydroimidazolone-1 (MG-H1) adduct, and it directly modifies intracellular proteins across multiple tissues. This clinically oriented narrative review synthesizes dicarbonyl chemistry, glyoxalase, and AGE adduct research to propose\u2014as a hypothesis-generating schema rather than established biology\u2014that MGO functions as a convergent biochemical node in diabetic complications. We examine MGO generation across the four input routes, its preferential modification of arginine and lysine residues, the correspondence between tissue MGO accumulation and complication distribution, glyoxalase-mediated clearance, and therapeutic strategies. We further propose that routine parameters such as gamma-glutamyl transferase and red cell distribution width may serve as accessible proxies for MGO burden, with the explicit caveat that these mappings require prospective validation and do not constitute a validated clinical instrument.<\/jats:p>","DOI":"10.3390\/biom16081104","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T08:16:52Z","timestamp":1785313012000},"page":"1104","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Methylglyoxal as a Convergent Mediator of Diabetic Complications: Generation, Protein Targets, Tissue Distribution, and Therapeutic Reduction\u2014A Clinically Oriented Mechanistic Synthesis"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4620-7712","authenticated-orcid":false,"given":"Enrique C.","family":"Fernandez","sequence":"first","affiliation":[{"name":"HCA Florida Kendall Hospital, Miami, FL 33175, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: A unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11892-013-0453-1","article-title":"Advanced glycation end products (AGE) and diabetes: Cause, effect, or both?","volume":"14","author":"Vlassara","year":"2014","journal-title":"Curr. Diabetes Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1152\/physrev.00001.2019","article-title":"Methylglyoxal, a highly reactive dicarbonyl compound, in diabetes, its vascular complications, and other age-related diseases","volume":"100","author":"Schalkwijk","year":"2020","journal-title":"Physiol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Fernandez, E.C. (2026). The three pathways of advanced glycation end product synthesis: Hodge, Namiki, and Wolff\u2014A clinically oriented mechanistic synthesis with network-based implications. Front. Endocrinol., 17.","DOI":"10.3389\/fendo.2026.1856036"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1021\/bk-1983-0215.ch002","article-title":"A new mechanism of the Maillard reaction involving sugar fragmentation and free radical formation","volume":"215","author":"Namiki","year":"1983","journal-title":"ACS Symp. Ser."},{"key":"ref_6","first-page":"29","article-title":"Role of sugar fragmentation in the Maillard reaction","volume":"13","author":"Hayashi","year":"1986","journal-title":"Dev. Food Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","article-title":"Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes","volume":"295","author":"Monnier","year":"2006","journal-title":"JAMA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1021\/jf60015a004","article-title":"Dehydrated foods: Chemistry of browning reactions in model systems","volume":"1","author":"Hodge","year":"1953","journal-title":"J. Agric. Food Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/bj3440109","article-title":"Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose","volume":"344","author":"Thornalley","year":"1999","journal-title":"Biochem. J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/diacare.27.7.1761","article-title":"Tests of glycemia in diabetes","volume":"27","author":"Goldstein","year":"2004","journal-title":"Diabetes Care"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/bj2450243","article-title":"Glucose autoxidation and protein modification. The potential role of \u2018autoxidative glycosylation\u2019 in diabetes","volume":"245","author":"Wolff","year":"1987","journal-title":"Biochem. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2337\/diab.39.11.1420","article-title":"Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose","volume":"39","author":"Hunt","year":"1990","journal-title":"Diabetes"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0014-5793(90)80974-N","article-title":"Hydrogen peroxide production during experimental protein glycation","volume":"268","author":"Jiang","year":"1990","journal-title":"FEBS Lett."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S2213-8587(13)70174-8","article-title":"Effects of iron overload on chronic metabolic diseases","volume":"2","author":"Manco","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1432-1033.1993.tb17638.x","article-title":"The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal","volume":"212","author":"Phillips","year":"1993","journal-title":"Eur. J. Biochem."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Allaman, I., B\u00e9langer, M., and Magistretti, P.J. (2015). Methylglyoxal, the dark side of glycolysis. Front. Neurosci., 9.","DOI":"10.3389\/fnins.2015.00023"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10719-016-9705-z","article-title":"Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics","volume":"33","author":"Rabbani","year":"2016","journal-title":"Glycoconj. J."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Va\u0161kov\u00e1, J., Kov\u00e1\u010dov\u00e1, G., Pudelsk\u00fd, J., Palen\u010d\u00e1r, D., and Mi\u010dkov\u00e1, H. (2025). Methylglyoxal formation\u2014Metabolic routes and consequences. Antioxidants, 14.","DOI":"10.3390\/antiox14020212"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"111905","DOI":"10.1016\/j.diabres.2024.111905","article-title":"Unraveling the impaired incretin effect in obesity and type 2 diabetes: Key role of hyperglycemia-induced unscheduled glycolysis and glycolytic overload","volume":"217","author":"Rabbani","year":"2024","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00726-010-0783-0","article-title":"Methylglyoxal, glyoxalase 1 and the dicarbonyl proteome","volume":"42","author":"Rabbani","year":"2012","journal-title":"Amino Acids"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1042\/bj3240565","article-title":"N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins","volume":"324","author":"Ahmed","year":"1997","journal-title":"Biochem. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10719-021-09980-0","article-title":"Dicarbonyl stress, protein glycation and the unfolded protein response","volume":"38","author":"Rabbani","year":"2021","journal-title":"Glycoconj. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"103025","DOI":"10.1016\/j.redox.2024.103025","article-title":"Increased cellular protein modification by methylglyoxal activates endoplasmic reticulum-based sensors of the unfolded protein response","volume":"69","author":"Xue","year":"2024","journal-title":"Redox Biol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Oliveira, A.L., de Oliveira, M.G., M\u00f3nica, F.Z., and Antunes, E. (2024). Methylglyoxal and advanced glycation end products (AGEs): Targets for the prevention and treatment of diabetes-associated bladder dysfunction?. Biomedicines, 12.","DOI":"10.3390\/biomedicines12050939"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Brings, S., Fleming, T., Fischler, M., Nawroth, P.P., and Sacks, D.B. (2017). Dicarbonyls and advanced glycation end products in the development of diabetic complications and targets for intervention. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18050984"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.tem.2022.11.004","article-title":"Advanced glycation endproducts in diabetes-related macrovascular complications: Focus on methylglyoxal","volume":"34","author":"Schalkwijk","year":"2023","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.gene.2012.11.009","article-title":"Identification of glyoxalase 1 polymorphisms associated with enzyme activity","volume":"515","author":"Peculis","year":"2013","journal-title":"Gene"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"103300","DOI":"10.1016\/j.redox.2024.103300","article-title":"Loss of NAMPT and SIRT2 but not SIRT1 attenuate GLO1 expression and activity in human skeletal muscle","volume":"75","author":"Miranda","year":"2024","journal-title":"Redox Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0098-2997(93)90002-U","article-title":"The glyoxalase system in health and disease","volume":"14","author":"Thornalley","year":"1993","journal-title":"Mol. Asp. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0009-2797(02)00212-0","article-title":"Methylglyoxal metabolism and diabetic complications: Roles of aldose reductase, glyoxalase-I, betaine aldehyde dehydrogenase and 2-oxoaldehyde dehydrogenase","volume":"143-144","author":"Hunsaker","year":"2003","journal-title":"Chem. Biol. Interact."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1177\/089686080902902S10","article-title":"Quantitation of markers of protein damage by glycation, oxidation, and nitration in peritoneal dialysis","volume":"29","author":"Rabbani","year":"2009","journal-title":"Perit. Dial. Int."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1042\/BJ20111648","article-title":"Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation","volume":"443","author":"Xue","year":"2012","journal-title":"Biochem. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/B978-0-12-420117-0.00003-7","article-title":"Gamma-glutamyl transpeptidase: Redox regulation and drug resistance","volume":"122","author":"Hanigan","year":"2014","journal-title":"Adv. Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Azarova, I., Klyosova, E., and Polonikov, A. (2021). The link between type 2 diabetes mellitus and the polymorphisms of glutathione-metabolizing genes suggests a new hypothesis explaining disease initiation and progression. Life, 11.","DOI":"10.3390\/life11090886"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Gong, S., Gan, S., Zhang, Y., Zhou, H., and Zhou, Q. (2023). Gamma-glutamyl transferase to high-density lipoprotein cholesterol ratio is a more powerful marker than the TyG index for predicting metabolic syndrome in patients with type 2 diabetes mellitus. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1248614"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1001\/archinte.164.19.2090","article-title":"Postprandial glucose regulation and diabetic complications","volume":"164","author":"Ceriello","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"DCCT Research Group (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med., 329, 977\u2013986.","DOI":"10.1056\/NEJM199309303291401"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study (UKPDS) Group (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 352, 837\u2013853.","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12933-017-0621-8","article-title":"Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: A pilot study","volume":"16","author":"Solini","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cmet.2013.02.007","article-title":"Iron and diabetes risk","volume":"17","author":"Simcox","year":"2013","journal-title":"Cell Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2337\/diabetes.48.1.198","article-title":"Metformin reduces systemic methylglyoxal levels in type 2 diabetes","volume":"48","author":"Beisswenger","year":"1999","journal-title":"Diabetes"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1055\/s-0034-1371818","article-title":"Effect of metformin on methylglyoxal metabolism in patients with type 2 diabetes","volume":"122","author":"Kender","year":"2014","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.coph.2007.04.005","article-title":"N-Acetylcysteine\u2014A safe antidote for cysteine\/glutathione deficiency","volume":"7","author":"Atkuri","year":"2007","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.2337\/dc11-0503","article-title":"Efficacy and safety of antioxidant treatment with \u03b1-lipoic acid over 4 years in diabetic polyneuropathy: The NATHAN 1 trial","volume":"34","author":"Ziegler","year":"2011","journal-title":"Diabetes Care"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1159\/000108104","article-title":"Effects of pyridoxamine in combined Phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy","volume":"27","author":"Williams","year":"2007","journal-title":"Am. J. Nephrol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/j.1582-4934.2010.01101.x","article-title":"The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats","volume":"15","author":"Aldini","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/jn\/nxy236","article-title":"Quercetin, but not epicatechin, decreases plasma concentrations of methylglyoxal in adults in a randomized, double-blind, placebo-controlled, crossover trial with pure flavonoids","volume":"148","author":"Geleijnse","year":"2018","journal-title":"J. Nutr."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/dom.14977","article-title":"Pyridoxamine reduces methylglyoxal and markers of glycation and endothelial dysfunction, but does not improve insulin sensitivity or vascular function in abdominally obese individuals: A randomized double-blind placebo-controlled trial","volume":"25","author":"Houben","year":"2023","journal-title":"Diabetes Obes. Metab."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Xue, M., Rabbani, N., and Thornalley, P.J. (2025). Glyoxalase 1 inducer, trans-resveratrol and hesperetin\u2014Dietary supplement with multi-modal health benefits. Antioxidants, 14.","DOI":"10.3390\/antiox14080956"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Rabbani, N., and Thornalley, P.J. (2022). Emerging glycation-based therapeutics\u2014Glyoxalase 1 inducers and glyoxalase 1 inhibitors. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23052453"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Rabbani, N., Xue, M., Weickert, M.O., and Thornalley, P.J. (2021). Reversal of insulin resistance in overweight and obese subjects by trans-resveratrol and hesperetin combination\u2014Link to dysglycemia, blood pressure, dyslipidemia, and low-grade inflammation. Nutrients, 13.","DOI":"10.3390\/nu13072374"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000075627","article-title":"Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy","volume":"24","author":"Bolton","year":"2004","journal-title":"Am. J. Nephrol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1161\/hc3801.097806","article-title":"Improved arterial compliance by a novel advanced glycation end-product crosslink breaker","volume":"104","author":"Kass","year":"2001","journal-title":"Circulation"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"108012","DOI":"10.1016\/j.jdiacomp.2021.108012","article-title":"The glycemic status determines the direction of the relationship between red cell distribution width and HbA1c","volume":"35","author":"Tsilingiris","year":"2021","journal-title":"J. Diabetes Complicat."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"818570","DOI":"10.1155\/2015\/818570","article-title":"Gamma-glutamyltransferase: A predictive biomarker of cellular antioxidant inadequacy and disease risk","volume":"2015","author":"Koenig","year":"2015","journal-title":"Dis. Markers"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.jdiacomp.2017.07.013","article-title":"Red cell distribution width is associated with hemoglobin A1C elevation, but not glucose elevation","volume":"31","author":"Bao","year":"2017","journal-title":"J. Diabetes Complicat."},{"key":"ref_57","first-page":"e66139","article-title":"Correlation of mean platelet volume and red cell distribution width with HbA1c and its association with microvascular complications in type 2 diabetes mellitus: A cross-sectional study at a tertiary hospital in India","volume":"16","author":"Dev","year":"2024","journal-title":"Cureus"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Liu, J., Wang, X., Gao, T.Y., Zhang, Q., Zhang, S.N., Xu, Y.Y., Yao, W.Q., Yang, Z.H., and Yan, H.J. (2024). Red blood cell distribution width to albumin ratio associates with prevalence and long-term diabetes mellitus prognosis: An overview of NHANES 1999-2020 data. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1362077"},{"key":"ref_59","first-page":"163","article-title":"Red cell distribution width as a surrogate biomarker for diabetic nephropathy, retinopathy, and vascular dysfunction","volume":"15","author":"Rehill","year":"2025","journal-title":"Eur. J. Cardiovasc. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1111\/jdi.70149","article-title":"Red blood cell distribution width is associated with renal tubular injury in individuals with type 2 diabetes","volume":"16","author":"Miyataka","year":"2025","journal-title":"J. Diabetes Investig."},{"key":"ref_61","first-page":"e42800","article-title":"Association of the red cell distribution width with the glycemic index and lipid profile in patients with type 2 diabetes mellitus","volume":"15","author":"Allahyani","year":"2023","journal-title":"Cureus"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.12669\/pjms.41.10.12622","article-title":"Association between red cell distribution width and its ratio with albumin and diabetic nephropathy\/retinopathy: A systematic review and meta-analysis","volume":"41","author":"Ma","year":"2025","journal-title":"Pak. J. Med. Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s00125-004-1451-2","article-title":"Simple non-invasive assessment of advanced glycation endproduct accumulation","volume":"47","author":"Meerwaldt","year":"2004","journal-title":"Diabetologia"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/8\/1104\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T08:41:55Z","timestamp":1785314515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/8\/1104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":65,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["biom16081104"],"URL":"https:\/\/doi.org\/10.3390\/biom16081104","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]}}}